1-7 of 7
Mattias Mattsson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Caspar Da Cunha-Bang, MD PhD, Rudy Agius, Arnon P. Kater, Mark-David Levin, MD PhD, Anders Österborg, MD PhD, Mattias Mattsson, MD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4304.
https://doi.org/10.1182/blood-2019-121907
Published: 2019
Journal Articles

Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial

Carsten Utoft Niemann, MD PhD, Julie Dubois, Sabina Kersting, MD PhD, Lisbeth Enggaard, MD, Gerrit J Veldhuis, Rogier Mous, MD PhD, Clemens Mellink, PhD, Johan A Dobber, Christian Bjørn Poulsen, MD, Henrik Frederiksen, MD Prof, Ann Janssens, Ida Schjødt, MD PhD, Ellen C Dompeling, Juha Ranti, Mattias Mattsson, MD, Mar Bellido, Hoa T Tran, Kazem Nasserinejad, Mark-David Levin, MD PhD, Arnon P. Kater, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4292.
https://doi.org/10.1182/blood-2019-124377
Published: 2019
Journal Articles

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression

Adalgisa Condoluci, MD, Lodovico Terzi di Bergamo, Lorenzo De Paoli, MD, Julio Delgado, MD, Massimo Gentile, MD, Michael Doubek, MD PhD, Francesca Romana Mauro, Mattias Mattsson, MD, Giovanna Cutrona, PhD, Jana Kotaskova, Clara Deambrogi, PhD, Bernhard Gerber, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Emanuele Zucca, Franco Cavalli, MD, Georg Stuessi, MD, Antonino Neri, MD, Manlio Ferrarini, MD, Richard Rosenquist, MD PhD, Robin Foà, MD, Sarka Pospisilova, Fortunato Morabito, MD, Emili Montserrat, MD, Gianluca Gaidano, MD PhD, William G. Wierda, MD PhD, Davide Rossi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1834.
https://doi.org/10.1182/blood-2018-99-116325
Published: 2018
Journal Articles

Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise—a Nationwide Population-Based Study from Sweden

Mattias Mattsson, MD, Fredrik Sandin, Eva Kimby, MD PhD, Martin Höglund, MD PhD, Ingrid Glimelius, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3120.
https://doi.org/10.1182/blood-2018-99-114058
Published: 2018
Journal Articles

Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

Maria Winqvist, MSc, MD, Per-Ola Andersson, MD PhD, Anna Asklid, MD, Karin Karlsson, MD, Claes Karlsson, MD PhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD Assoc Prof, Mattias Mattsson, MD, Stefan Norin, MD PhD, Anna Bergendahl Sandstedt, MD, Lotta Hansson, Anders Österborg, MD PhD Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 5353.
https://doi.org/10.1182/blood.V130.Suppl_1.5353.5353
Published: 2017
Journal Articles

Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013

Sandra Eketorp Sylvan, MD PhD, Anna Asklid, MD, Hemming Johansson, Jenny Klintman, MD PhD, Jenny Bjellvi, MD, Staffan Tolvgård, MD, Eva Kimby, Stefan Norin, MD PhD, P-O Andersson, MD PhD Prof., Claes Karlsson, MD PhD, Karin Karlsson, MD, Birgitta Lauri, MD, Mattias Mattsson, MD, Anna Bergendahl Sandstedt, MD, Maria Strandberg, MD, Anders Österborg, MD PhD Prof., Lotta Hansson
Journal: Blood
Blood (2017) 130 (Supplement 1): 1744.
https://doi.org/10.1182/blood.V130.Suppl_1.1744.1744
Published: 2017
Journal Articles

Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program

Lotta Hansson, MD PhD, Maria Winqvist, MD, Anna Asklid, MD, P-O Andersson, MDPhD, Karin Karlsson, MD, Claes Karlsson, MDPhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD, Mattias Mattsson, MD, Stefan Norin, MDPhD, Anna Sandstedt, MD, Anders Österborg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1745.
https://doi.org/10.1182/blood.V126.23.1745.1745
Published: 2015